9. Marelli L, Stigliano R, Triantos C et al. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc. Intervent. Radiol.30(1),6–25 (2007).（Meta-analysis comparing TACE/TAE/TOCE with conservative or suboptimal treatment. Transarterial therapies significantly decreased mortality. TACE and TAE achieved the same survival benefit）. 10. Nakashima T, Kojiro M. Pathologic characteristics of hepatocellular carcinoma. Semin. Liver Dis.6(3),259–266 (1986). 11. Chang JM, Tzeng WS, Pan HB et al. Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma. A randomized controlled study. Cancer74(9),2449–2453 (1994). 12. Kawai S, Okamura J, Ogawa M et al. Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma – a comparison of lipiodol-transcatheter arterial embolization with and without adriamycin (first cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan. Cancer Chemother. Pharmacol.31(Suppl.),S1–S6 (1992). 13. Graziadei IW, Sandmueller H, Waldenberger P et al. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl.9(6),557–563 (2003). |